EN DE

Netcare Limited (NWKHY) Fair Value & Analysis

Healthcare · US · Market cap $1.0B

NL Netcare Limited logo Netcare Limited NWKHY · US
Price$7.17
Fair Value$12.06
Upside+68.2%
Quality59/100
Watch Netcare Limited for free, get notified when fair value or trend changes. Watch for free
Expensive Growth
Thin margins · 6.8% net margin
Moderate debt · generates free cash flow
5.80% dividend yield
Ranks above peers (9/11)
Moderate moat 55/100
Evidence: High Range $6.24 – $21.19 Share as image

Fair value as of: Jul 19, 2026

From 22 valuation models · updated 22 days ago

Fair value updated Jul 19, 2026, revised from $12.00 to $12.06 (+0.5%) since Jun 24, 2026.

A solid business, screening 68% undervalued on our models.

What matters now

  • The model range is unusually wide ($6.24 to $21.19). The outcome hinges heavily on assumptions, so read the point estimate with caution.
  • Solid quality (59/100) at a price below fair value, the discount is the argument here, not the business quality.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

$17.69 $5.51 Fair Value $12.06 Jan 2017 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 19, 2026.

How to read this chart

60‑month range $5.51 – $17.69 · fair‑value band $6.24 – $21.19 · the $7.17 price screens below the $12.06 fair value. Dashed = 300-day average. As of Jul 19, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Netcare Limited (NWKHY) currently trades at $7.17, while our model-based Fair Value estimate is $12.06, implying the stock looks roughly 68.2% undervalued today. The Quality Score stands at 59/100 (solid quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high), always confirm before acting.

Over the trailing twelve months, Netcare Limited generated revenue of $26.9B at a net margin of 6.8%. Revenue grew 4.8% year over year. It earns a return on equity of 17.6%. Net debt stands at $11.1B. Fundamentals as of Jul 19, 2026

Our scenario range runs from $6.24 (bear case) to $21.19 (bull case); at $7.17, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 8% below its 52-week high, currently above its 200-day average. For context, the median of 10 Healthcare peers we cover trades at 11% fair-value upside, at 68%, NWKHY screens cheaper than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model BearBaseBull Evidence
Highest evidence
Residual Income $90.61 $118.36 $332.13 76
ROIC Compounder $95.92 $119.86 $145.11 72
Gordon GGM $3.79 $5.89 $7.96 70
All 22 models by family
DCF Models
Owner Earnings $188.16 $268.24 $367.28 31
5Y Revenue Exit $77.89 $168.65 $282.73 39
5Y EBITDA Exit $149.55 $295.89 $461.45 41
5Y P/E Exit $88.24 $187.02 $286.25 38
10Y Revenue Exit $25.05 $92.03 $178.19 36
10Y EBITDA Exit $71.11 $170.55 $296.97 37
10Y P/E Exit $36.08 $103.36 $180.53 35
Earnings-Based
Graham-Dodd $102.62 $240.24 $309.01 54
PEG = 1.0 $41.10 $58.71 $76.32 46
EPV $95.71 $114.57 $130.28 59
Dividend Discount
Gordon GGM $3.79 $5.89 $7.96 70
DDM Multi-Stage $3.79 $5.29 $6.74 61
Multiples
P/E Multiple $249.02 $332.02 $415.03 63
P/S Multiple $192.42 $256.56 $320.70 58
P/B Multiple $192.42 $256.56 $320.70 55
EV/EBIT $256.53 $356.22 $455.92 53
EV/EBITDA $326.75 $449.86 $572.96 54
EV/Revenue $170.90 $262.39 $353.88 43
Asset-Based
NCAV (Graham) $47.06 $63.07 $94.13 50
Economic Profit
Residual Income $90.61 $118.36 $332.13 76
ROIC Compounder $95.92 $119.86 $145.11 72
Growth Earnings
Growth-Adj P/E $187.68 $268.11 $348.54 68

Widest divergence: Growth Earnings ($268.11) versus Dividend Discount ($5.29). Highest evidence: Residual Income (76).

Key figures & financial health

Revenue (TTM) $26.9B
Revenue growth (YoY) +4.8%
Net margin 6.8%
Return on equity 17.6%
Free cash flow $122M FY2025
P/E ratio 12.6
More key figures
Operating margin 13.2%
EPS (TTM) $0.6900
Dividend yield 5.8%
EPS growth (YoY) +19.1%
Net debt $11.1B FY2025

Figures from reported company fundamentals · as of Jul 19, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 59/100

Of which business quality 53 · Market factors (momentum, volatility) 52

Profitability 58
Margins and returns on capital today
Quality Growth 43
Are margins and returns improving?
Cashflow 19
Earnings quality: real cash, not paper profit
Fin. Strength 38
Balance sheet, leverage, solvency risk
Investment 94
Disciplined investing over empire-building
Low Volatility 100
Calm price path (market factor)
Momentum 41
Price trend over the last 3–12 months (market factor)
52W Momentum 17
Distance to the 52-week high (market factor)
Net Issuance 100
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

Netcare Limited, an investment holding company, operates private hospitals in South Africa. It operates through Hospital and Emergency Services, and Primary Care segments. The Hospital and Emergency Services segment engages in the hospital and pharmacy operations.

Full company description

Netcare Limited, an investment holding company, operates private hospitals in South Africa. It operates through Hospital and Emergency Services, and Primary Care segments. The Hospital and Emergency Services segment engages in the hospital and pharmacy operations. Its operations covers its private acute hospital network and day clinics; and non-acute services, including emergency medical services, mental health clinics operation, diagnostics support services, and cancer care services, as well as sells healthcare products. The Primary Care segment offers healthcare services, and employee health and wellness services, as well as administrative services to medical and dental practices. It also engages in the financing, property owning, and pharmaceutical services. It operates through a network of acute hospitals, netcare 911 sites, cancer care centres, haematology centres, renal dialysis facilities, dialysis stations, point of care devices, mental health hospitals, primary health care facilities, and occupational health service contracts, as well as insurance products, and prepaid procedures and healthcare vouchers. Netcare Limited was incorporated in 1996 and is headquartered in Sandton, South Africa.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Netcare Limited reported revenue of $26.3B in FY2025 versus $21.2B in FY2021, a compound +5.6%/yr. Reported net income was $1.7B in FY2025, compounding +22.7%/yr from FY2021.

Growth Quality 58/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Latest Revenue (FY 2025)
$26.3B
Latest YoY
+4.5%
Avg. growth/yr (3Y)
+6.8%
Avg. growth/yr (5Y)
+6.9%
Avg. growth/yr (20Y)
+6.5%
Revenue +5.6%/yr
FY21 $21.2B
FY22 $21.6B
FY23 $23.7B
FY24 $25.2B
FY25 $26.3B
Net income +22.7%/yr
FY21 $769M
FY22 $1.0B
FY23 $1.3B
FY24 $1.5B
FY25 $1.7B

Watch NWKHY: get an alert when its fair value changes →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Netcare Limited Fair Value". https://www.fairvalue-calculator.com/stock/NWKHY

Peer Group

Medical Care Facilities · 262 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 59 · Above median
Fair Value upside +68% · Top 25%
Return on equity (TTM) 18% · Top 25%
Return on assets 8% · Top 25%
Net margin (TTM) 7% · Above median
Operating margin (TTM) 13% · Above median
Revenue growth 5% · Above median
Dividend yield (TTM) 5.8% · Top 25%
Debt / equity 0.63× · Higher than 75% of peers

Valuation Multiples vs Medical Care Facilities median · lower = cheaper

P/E (TTM) 12.6× · Cheaper than 75% of peers
P/FCF 8.2× · Pricier than median

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 100 · sector 22
FUTURE 24 · sector 24
PAST 70 · sector 30
HEALTH 69 · sector 90
DIVIDEND 100 · sector 38

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate (as of Jul 19, 2026).

Stock Price Fair Value vs Fair Value
HCA Healthcare, Inc HCA $378.85 $554.93 +46%
Fresenius SE FRE €41.73 €32.15 -23%
Dr. Sulaiman Al Habib Medical Services Group 4013 235.00 SAR 112.37 SAR -52%
IHH Healthcare Berhad, an investment holding company, Q0F 2.58 SGD 1.44 SGD -44%
Tenet Healthcare Corporation THC $194.91 $338.05 +73%
Rede D'Or São Luiz S.A RDOR3 R$36.01 R$47.31 +31%
DaVita Inc DVA $231.61 $255.97 +11%
Apollo Hospitals Enterprise Limited APOLLOHOSP ₹8,955 ₹2,955 -67%
Fresenius Medical Care AG FMS $24.68 $45.60 +85%
Aier Eye Hospital Group 300015 ¥8.68 ¥7.67 -12%

Compare Netcare Limited with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is Netcare Limited (NWKHY) overvalued or undervalued?
As of Jul 19, 2026, our model estimates a fair value of $12.06 versus a price of $7.17, about +68% (undervalued).
What is the fair value of NWKHY?
Our model-based fair value for Netcare Limited is $12.06 (as of Jul 19, 2026), built from audited fundamentals. The current price is $7.17.
What is the quality score of NWKHY?
Netcare Limited has a Quality Score of 59/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Netcare Limited (NWKHY)?
Netcare Limited reported trailing-twelve-month revenue of about $26.9B (latest available figure, as of Jul 19, 2026).
What is the net profit margin of NWKHY?
The net profit margin of Netcare Limited is about 6.8%, meaning it keeps roughly 6.8% of revenue as net income. Based on the latest reported figures.
Does Netcare Limited pay a dividend?
Netcare Limited currently shows a dividend yield of about 5.80% relative to its recent price (as of Jul 19, 2026).

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track Netcare Limited and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.